- Published on
Ophthalmology – Aicardi Syndrome
Aicardi syndrome is a rare genetic neurodevelopmental disorder classically defined by a triad of infantile spasms, agenesis of the corpus callosum, and distinctive chorioretinal lacunae. It primarily affects females and is presumed to follow an X-linked dominant inheritance pattern that is typically lethal in males, with rare surviving males often having chromosomal abnormalities such as XXY. The condition is extremely rare, with only several thousand cases reported worldwide. The exact gene responsible has not been definitively identified, and the disorder is thought to arise from a developmental defect of neuroectodermal origin.
The syndrome is associated with a wide range of ocular and systemic abnormalities. The hallmark ocular finding is chorioretinal lacunae, which are areas of retinal pigment epithelium and choroidal atrophy with disrupted overlying retinal architecture. Additional ocular features may include optic disc anomalies such as coloboma or hypoplasia, microphthalmia, retinal detachment, and nystagmus. Systemically, patients often have significant central nervous system malformations, including partial or complete agenesis of the corpus callosum, cortical malformations such as polymicrogyria or pachygyria, heterotopias, intracranial cysts, ventriculomegaly, and cerebral asymmetry. Other associated abnormalities include vertebral and rib malformations, hypotonia, microcephaly, dysmorphic facial features, gastrointestinal disturbances, and skin lesions. Severe developmental delay and intellectual disability are common.
Affected infants typically present between 3 and 5 months of age with neurological symptoms such as developmental delay, hypotonia, and intractable infantile spasms. Ocular findings such as decreased visual acuity, amblyopia, or strabismus may also be noted. Diagnosis is based on clinical features, with the presence of the classic triad being diagnostic. Cases with two components of the triad plus additional major or supporting features are strongly suggestive. Neuroimaging, particularly MRI, is essential to identify structural brain abnormalities, and EEG often demonstrates characteristic patterns such as hypsarrhythmia associated with infantile spasms. Routine laboratory tests are typically normal, although genetic testing such as karyotyping and microarray analysis may be performed to evaluate chromosomal abnormalities.
The differential diagnosis includes other conditions with corpus callosum agenesis, neuronal migration disorders, infantile spasms of other etiologies, and syndromes with overlapping ocular or neurological findings such as oculocerebrocutaneous syndrome. Chorioretinal lacunae are considered highly characteristic of Aicardi syndrome but may rarely be seen in other conditions.
Management is supportive and multidisciplinary, focusing on seizure control and addressing developmental and systemic complications. Antiepileptic medications, particularly vigabatrin, are commonly used, and some patients may benefit from vagus nerve stimulation. Physical, occupational, and speech therapies are important for supportive care. Regular ophthalmologic follow-up is recommended, particularly if medications such as vigabatrin are used due to potential retinal toxicity. Referral to neurology and other specialties is often necessary to manage the complex needs of these patients.
Prognosis is variable but generally poor due to severe neurological impairment. Many patients have significant developmental delay and require lifelong care. Vision is often limited more by cortical visual impairment than by ocular abnormalities unless the macula is involved. Life expectancy is reduced, with many patients succumbing to complications such as intractable seizures, aspiration, or complications related to severe neurological disability, although some individuals may survive into adolescence or adulthood.
Aicardi syndrome is a rare genetic neurodevelopmental disorder classically defined by a triad of infantile spasms, agenesis of the corpus callosum, and distinctive chorioretinal lacunae. It primarily affects females and is presumed to follow an X-linked dominant inheritance pattern that is typically lethal in males, with rare surviving males often having chromosomal abnormalities such as XXY. The condition is extremely rare, with only several thousand cases reported worldwide. The exact gene responsible has not been definitively identified, and the disorder is thought to arise from a developmental defect of neuroectodermal origin.
The syndrome is associated with a wide range of ocular and systemic abnormalities. The hallmark ocular finding is chorioretinal lacunae, which are areas of retinal pigment epithelium and choroidal atrophy with disrupted overlying retinal architecture. Additional ocular features may include optic disc anomalies such as coloboma or hypoplasia, microphthalmia, retinal detachment, and nystagmus. Systemically, patients often have significant central nervous system malformations, including partial or complete agenesis of the corpus callosum, cortical malformations such as polymicrogyria or pachygyria, heterotopias, intracranial cysts, ventriculomegaly, and cerebral asymmetry. Other associated abnormalities include vertebral and rib malformations, hypotonia, microcephaly, dysmorphic facial features, gastrointestinal disturbances, and skin lesions. Severe developmental delay and intellectual disability are common.
Affected infants typically present between 3 and 5 months of age with neurological symptoms such as developmental delay, hypotonia, and intractable infantile spasms. Ocular findings such as decreased visual acuity, amblyopia, or strabismus may also be noted. Diagnosis is based on clinical features, with the presence of the classic triad being diagnostic. Cases with two components of the triad plus additional major or supporting features are strongly suggestive. Neuroimaging, particularly MRI, is essential to identify structural brain abnormalities, and EEG often demonstrates characteristic patterns such as hypsarrhythmia associated with infantile spasms. Routine laboratory tests are typically normal, although genetic testing such as karyotyping and microarray analysis may be performed to evaluate chromosomal abnormalities.
The differential diagnosis includes other conditions with corpus callosum agenesis, neuronal migration disorders, infantile spasms of other etiologies, and syndromes with overlapping ocular or neurological findings such as oculocerebrocutaneous syndrome. Chorioretinal lacunae are considered highly characteristic of Aicardi syndrome but may rarely be seen in other conditions.
Management is supportive and multidisciplinary, focusing on seizure control and addressing developmental and systemic complications. Antiepileptic medications, particularly vigabatrin, are commonly used, and some patients may benefit from vagus nerve stimulation. Physical, occupational, and speech therapies are important for supportive care. Regular ophthalmologic follow-up is recommended, particularly if medications such as vigabatrin are used due to potential retinal toxicity. Referral to neurology and other specialties is often necessary to manage the complex needs of these patients.
Prognosis is variable but generally poor due to severe neurological impairment. Many patients have significant developmental delay and require lifelong care. Vision is often limited more by cortical visual impairment than by ocular abnormalities unless the macula is involved. Life expectancy is reduced, with many patients succumbing to complications such as intractable seizures, aspiration, or complications related to severe neurological disability, although some individuals may survive into adolescence or adulthood.
0 Comments
